FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899696857> ?p ?o ?g. }

• W2899696857 endingPage "371" @default.
• W2899696857 startingPage "361" @default.
• W2899696857 abstract "Obesity increases the risk of hormone receptor–positive breast cancer in postmenopausal women. Levels of aromatase, the rate-limiting enzyme in estrogen biosynthesis, are increased in the breast tissue of obese women. Both prostaglandin E2 (PGE2) and hypoxia-inducible factor 1α (HIF-1α) contribute to the induction of aromatase in adipose stromal cells (ASCs). Sirtuin 1 (SIRT1) binds, deacetylates, and thereby inactivates HIF-1α. Here, we sought to determine whether SIRT1 also plays a role in regulating aromatase expression. We demonstrate that reduced SIRT1 levels are associated with elevated levels of acetyl–HIF-1α, HIF-1α, and aromatase in breast tissue of obese compared with lean women. To determine whether these changes were functionally linked, ASCs were utilized. In ASCs, treatment with PGE2, which is increased in obese individuals, down-regulated SIRT1 levels, leading to elevated acetyl–HIF-1α and HIF-1α levels and enhanced aromatase gene transcription. Chemical SIRT1 activators (SIRT1720 and resveratrol) suppressed the PGE2-mediated induction of acetyl–HIF-1α, HIF-1α, and aromatase. Silencing of p300/CBP-associated factor (PCAF), which acetylates HIF-1α, blocked PGE2-mediated increases in acetyl–HIF-1α, HIF-1α, and aromatase. SIRT1 overexpression or PCAF silencing inhibited the interaction between HIF-1α and p300, a coactivator of aromatase expression, and suppressed p300 binding to the aromatase promoter. PGE2 acted via prostaglandin E2 receptor 2 (EP2) and EP4 to induce activating transcription factor 3 (ATF3), a repressive transcription factor, which bound to a CREB site within the SIRT1 promoter and reduced SIRT1 levels. These findings suggest that reduced SIRT1-mediated deacetylation of HIF-1α contributes to the elevated levels of aromatase in breast tissues of obese women. Obesity increases the risk of hormone receptor–positive breast cancer in postmenopausal women. Levels of aromatase, the rate-limiting enzyme in estrogen biosynthesis, are increased in the breast tissue of obese women. Both prostaglandin E2 (PGE2) and hypoxia-inducible factor 1α (HIF-1α) contribute to the induction of aromatase in adipose stromal cells (ASCs). Sirtuin 1 (SIRT1) binds, deacetylates, and thereby inactivates HIF-1α. Here, we sought to determine whether SIRT1 also plays a role in regulating aromatase expression. We demonstrate that reduced SIRT1 levels are associated with elevated levels of acetyl–HIF-1α, HIF-1α, and aromatase in breast tissue of obese compared with lean women. To determine whether these changes were functionally linked, ASCs were utilized. In ASCs, treatment with PGE2, which is increased in obese individuals, down-regulated SIRT1 levels, leading to elevated acetyl–HIF-1α and HIF-1α levels and enhanced aromatase gene transcription. Chemical SIRT1 activators (SIRT1720 and resveratrol) suppressed the PGE2-mediated induction of acetyl–HIF-1α, HIF-1α, and aromatase. Silencing of p300/CBP-associated factor (PCAF), which acetylates HIF-1α, blocked PGE2-mediated increases in acetyl–HIF-1α, HIF-1α, and aromatase. SIRT1 overexpression or PCAF silencing inhibited the interaction between HIF-1α and p300, a coactivator of aromatase expression, and suppressed p300 binding to the aromatase promoter. PGE2 acted via prostaglandin E2 receptor 2 (EP2) and EP4 to induce activating transcription factor 3 (ATF3), a repressive transcription factor, which bound to a CREB site within the SIRT1 promoter and reduced SIRT1 levels. These findings suggest that reduced SIRT1-mediated deacetylation of HIF-1α contributes to the elevated levels of aromatase in breast tissues of obese women." @default.
• W2899696857 created "2018-11-16" @default.
• W2899696857 creator A5002918170 @default.
• W2899696857 creator A5013077524 @default.
• W2899696857 creator A5030289564 @default.
• W2899696857 creator A5056370132 @default.
• W2899696857 creator A5061702711 @default.
• W2899696857 creator A5063692897 @default.
• W2899696857 date "2019-01-01" @default.
• W2899696857 modified "2023-10-13" @default.
• W2899696857 title "Prostaglandin E2 down-regulates sirtuin 1 (SIRT1), leading to elevated levels of aromatase, providing insights into the obesity–breast cancer connection" @default.
• W2899696857 cites W1775749144 @default.
• W2899696857 cites W1963685103 @default.
• W2899696857 cites W1964804181 @default.
• W2899696857 cites W1974196451 @default.
• W2899696857 cites W1975347641 @default.
• W2899696857 cites W1976980661 @default.
• W2899696857 cites W2011376105 @default.
• W2899696857 cites W2022451432 @default.
• W2899696857 cites W2027616087 @default.
• W2899696857 cites W2032619751 @default.
• W2899696857 cites W2036221290 @default.
• W2899696857 cites W2056564149 @default.
• W2899696857 cites W2061865489 @default.
• W2899696857 cites W2070002432 @default.
• W2899696857 cites W2095287847 @default.
• W2899696857 cites W2097791540 @default.
• W2899696857 cites W2099687396 @default.
• W2899696857 cites W2101720365 @default.
• W2899696857 cites W2103213014 @default.
• W2899696857 cites W2104022651 @default.
• W2899696857 cites W2114397636 @default.
• W2899696857 cites W2115076934 @default.
• W2899696857 cites W2128064492 @default.
• W2899696857 cites W2131080865 @default.
• W2899696857 cites W2141662760 @default.
• W2899696857 cites W2148391873 @default.
• W2899696857 cites W2148435735 @default.
• W2899696857 cites W2148619403 @default.
• W2899696857 cites W2150805233 @default.
• W2899696857 cites W2151014103 @default.
• W2899696857 cites W2166381966 @default.
• W2899696857 cites W2169259762 @default.
• W2899696857 cites W2171087521 @default.
• W2899696857 cites W2216971459 @default.
• W2899696857 cites W2418523864 @default.
• W2899696857 cites W2494936690 @default.
• W2899696857 cites W2511868650 @default.
• W2899696857 cites W2591635052 @default.
• W2899696857 cites W2767326639 @default.
• W2899696857 cites W2769082168 @default.
• W2899696857 cites W4229680397 @default.
• W2899696857 doi "https://doi.org/10.1074/jbc.ra118.005866" @default.
• W2899696857 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6322870" @default.
• W2899696857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30409902" @default.
• W2899696857 hasPublicationYear "2019" @default.
• W2899696857 type Work @default.
• W2899696857 sameAs 2899696857 @default.
• W2899696857 citedByCount "16" @default.
• W2899696857 countsByYear W28996968572019 @default.
• W2899696857 countsByYear W28996968572020 @default.
• W2899696857 countsByYear W28996968572021 @default.
• W2899696857 countsByYear W28996968572022 @default.
• W2899696857 countsByYear W28996968572023 @default.
• W2899696857 crossrefType "journal-article" @default.
• W2899696857 hasAuthorship W2899696857A5002918170 @default.
• W2899696857 hasAuthorship W2899696857A5013077524 @default.
• W2899696857 hasAuthorship W2899696857A5030289564 @default.
• W2899696857 hasAuthorship W2899696857A5056370132 @default.
• W2899696857 hasAuthorship W2899696857A5061702711 @default.
• W2899696857 hasAuthorship W2899696857A5063692897 @default.
• W2899696857 hasBestOaLocation W28996968571 @default.
• W2899696857 hasConcept C104317684 @default.
• W2899696857 hasConcept C119056186 @default.
• W2899696857 hasConcept C121608353 @default.
• W2899696857 hasConcept C126322002 @default.
• W2899696857 hasConcept C127561419 @default.
• W2899696857 hasConcept C134018914 @default.
• W2899696857 hasConcept C181199279 @default.
• W2899696857 hasConcept C185592680 @default.
• W2899696857 hasConcept C2776166826 @default.
• W2899696857 hasConcept C2776536020 @default.
• W2899696857 hasConcept C2780561631 @default.
• W2899696857 hasConcept C502942594 @default.
• W2899696857 hasConcept C530470458 @default.
• W2899696857 hasConcept C55493867 @default.
• W2899696857 hasConcept C71924100 @default.
• W2899696857 hasConcept C75520062 @default.
• W2899696857 hasConcept C77445288 @default.
• W2899696857 hasConcept C86339819 @default.
• W2899696857 hasConcept C86803240 @default.
• W2899696857 hasConceptScore W2899696857C104317684 @default.
• W2899696857 hasConceptScore W2899696857C119056186 @default.
• W2899696857 hasConceptScore W2899696857C121608353 @default.
• W2899696857 hasConceptScore W2899696857C126322002 @default.
• W2899696857 hasConceptScore W2899696857C127561419 @default.
• W2899696857 hasConceptScore W2899696857C134018914 @default.
• W2899696857 hasConceptScore W2899696857C181199279 @default.

• next